| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000014668 |
| Receipt No. | R000017061 |
| Official scientific title of the study | A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection |
| Date of disclosure of the study information | 2014/08/15 |
| Last modified on | 2017/01/28 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection | |
| Title of the study (Brief title) | MOVI STUDY | |
| Region |
|
|
| Condition | |||
| Condition | Colorectal tumor | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To compare the effect of Moviprep (low-volume colonoscopy prep) and Muben (standard-volume) on the bowel preparation for the patients undergo colorectal endoscopic submucosal dissection. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Preparation time |
| Key secondary outcomes | Boston Bowel Preparation Scale score, acceptability, taste, frequencies of stool, total volume of the prep, complication rate. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Moviprep 1.5L ~ 2L | |
| Interventions/Control_2 | Muben 3L ~ 4L | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent colorectal endoscopic submucosal dissection (ESD) at National Cancer Center Hospital.
1. Indication for colorectal ESD 2. Irrespective of number of the lesion 3. Age from 20 years old to 75 years old 4. Performance status 0, 1, 2 5. Patients who has written informed consent for this study |
|||
| Key exclusion criteria | 1. Patients having risk of perforation, obstruction and suspicious of ileum.
2. Toxic megacolon 3. Allergy for Moviprep and Muben 4. Dehydration 5. Mental disease 6. Without written informed consent 7. Angina pectoris and/or past history of myocardial infarction within 6 months. 8. Active inflammatory bowel diseases 9. Past history of convulsive attack 10. Serum creatinine level ≥1.3 mg/dL 11. Others (depends on the chief physician) |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Takahisa Matsuda |
| Organization | National Cancer Center Hospital |
| Division name | Endoscopy Division |
| Address | 5-1-1, Tsukiji, Chuo-ku, Tokyo |
| TEL | +81-3-3542-2511 |
| tamatsud@ncc.go.jp | |
| Public contact | |
| Name of contact person | Masayoshi Yamada |
| Organization | National Cancer Center Hospital |
| Division name | Endoscopy Division |
| Address | 5-1-1, Tsukiji, Chuo-ku, Tokyo |
| TEL | +81-3-3542-2511 |
| Homepage URL | |
| masyamad@ncc.go.jp | |
| Sponsor | |
| Institute | National Cancer Center Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ajinomoto Pharmaceuticals Co., LTD |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立がん研究センター中央病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017061 |